|
|
Autism Research Institute
Autism Research Review International
1987 to 2004, Volumes 1 to 18
P
P-Touch Electronic Labeling device, 1992, Vol. 06(4) pp. 3
"pacemaker " (vagus nerve stimulator), 1997, Vol. 11(4) pp. 2; 2001, Vol. 15(2) pp. 7; 2002, Vol. 16(3) pp. 5.
Page, Ted, 2001, Vol. 15(1) pp. 7
pagers, 2004, Vol. 18(2) pp. 5
Pahl, Jan, 1987, Vol. 01(2) pp. 4
pain
pain threshold, 1993, Vol. 07(4) pp. 4; 1994, Vol. 08(3) pp. 2.
Palace, J., 2001, Vol. 15(1) pp. 7
Palfreman, John, 1993, Vol. 07(4) pp. 7
palm creases, 1990, Vol. 04(2) pp. 4
Palmer, Monica Rourke, 1992, Vol. 06(1) pp. 7
Palmer, Pat, 1998, Vol. 12(3) pp. 2; 1999, Vol. 13(2) pp. 6.
pancreatic dysfunction, 2000, Vol. 14(3) pp. 6
PANDAS. See pediatric autoimmune neuropsychiatric disorders (PANDAS)
Paneth cell hyperplasia, 1999, Vol. 13(4) pp. 7
pangamic acid (vitamin B15), 1990, Vol. 04(2) pp. 3
Pangborn, Jon
DAN!, 1996, Vol. 10(1) pp. 1; 2002, Vol. 16(2) pp. 3; 2002, Vol. 16(3) pp. 1; 2003, Vol. 17(4) pp. 3.
letter to Mark McClelland, 2003, Vol. 17(2) pp. 3
on peptidase enzyme, 2000, Vol. 14(1) pp. 6; 2002, Vol. 16(1) pp. 3.
on phenols, 2002, Vol. 16(1) pp. 7
publications, 2000, Vol. 14(3) pp. 4; 2001, Vol. 15(1) pp. 3; 2002, Vol. 16(2) pp. 3.
on Specific Carbohydrate Diet, 2004, Vol. 18(3) pp. 3
panic attacks, 1999, Vol. 13(1) pp. 2; 2001, Vol. 15(1) pp. 6.
Panksepp, Jaak
auditory integration study, 1995, Vol. 09(4) pp. 2
Los Children Fund, 1991, Vol. 05(4) pp. 4
naltrexone study, 1987, Vol. 01(2) pp. 1; 1992, Vol. 06(1) pp. 1; 1992, Vol. 06(2) pp. 2.
opioids and autism, 1991, Vol. 05(4) pp. 1
oxytocin, 1993, Vol. 07(4) pp. 4; 1996, Vol. 10(3) pp. 2.
Papanikolaou, P.N., 2004, Vol. 18(4) pp. 4
paranoid symptoms, 1998, Vol. 12(2) pp. 3
parathyroid hormone, 1998, Vol. 12(3) pp. 6
Pardo, Sandra Bosso, 1992, Vol. 06(4) pp. 6
Parent Idea Book (compiled by International Rett Symdrome Association), 1989, Vol. 03(4) pp. 7
Parent Ratings of Teatments, 2004, Vol. 18(3) pp. 3
parents, 1994, Vol. 08(3) pp. 4. See also family of autistics
"pareve" label, 2000, Vol. 14(3) pp. 6
parietal lobe abnormalities, 1990, Vol. 04(2) pp. 4; 1993, Vol. 07(3) pp. 4; 1994, Vol. 08(2) pp. 1; 1994, Vol. 08(3) pp. 5; 1997, Vol. 11(1) pp. 1; 2001, Vol. 15(2) pp. 4.
PARISS genetic study, 2000, Vol. 14(1) pp. 2
Park, Clara, 1990, Vol. 04(1) pp. 7
parkinsonism, 1997, Vol. 11(1) pp. 4; 2000, Vol. 14(4) pp. 4; 2003, Vol. 17(4) pp. 4.
Parkinson's, 1989, Vol. 03(3) pp. 7; 2001, Vol. 15(3) pp. 7; 2001, Vol. 15(4) pp. 2; 2002, Vol. 16(3) pp. 4.
paroxetine (Paxil), 2002, Vol. 16(4) pp. 6; 2003, Vol. 17(3) pp. 2; 2004, Vol. 18(1) pp. 9; 2004, Vol. 18(2) pp. 4; 2004, Vol. 18(3) pp. 2.
Parr, Janette M., 1989, Vol. 03(3) pp. 5
Parsons, S., 2002, Vol. 16(3) pp. 5
partial reinforcement, 1994, Vol. 08(3) pp. 5
Partington, M. W., 1998, Vol. 12(3) pp. 5
passive behavior, 2002, Vol. 16(3) pp. 1; 2003, Vol. 17(4) pp. 6.
patent theft, 2002, Vol. 16(1) pp. 3
pathological demand avoidance syndrome (PDA), 2003, Vol. 17(4) pp. 6
pattern recognition in savants, 1989, Vol. 03(1) pp. 7
Paul, Rhea, 1988, Vol. 02(4) pp. 7
Paul-Brown, Diane, 1994, Vol. 08(3) pp. 7
Pauling, Linus, 1995, Vol. 09(1) pp. 2; 1997, Vol. 11(4) pp. 3; 2000, Vol. 14(3) pp. 3.
Pavley, Fran (Assemblywoman), 2004, Vol. 18(3) pp. 1
Paxil (paroxetine), 2002, Vol. 16(4) pp. 6; 2003, Vol. 17(3) pp. 2; 2004, Vol. 18(1) pp. 9; 2004, Vol. 18(2) pp. 4; 2004, Vol. 18(3) pp. 2.
PC language, 1992, Vol. 06(3) pp. 6; 1993, Vol. 07(4) pp. 3; 1994, Vol. 08(1) pp. 6.
PCR test, 1995, Vol. 09(3) pp. 1
PDA (pathological demand avoidance syndrome), 2003, Vol. 17(4) pp. 6
PDD. See pervasive developmental disorder
Peale, Norman Vincent, 1994, Vol. 08(3) pp. 6
Peck, Charles, 1988, Vol. 02(1) pp. 6; 1988, Vol. 02(2) pp. 6; 1994, Vol. 08(4) pp. 6.
PECS (Picture-Exchange Communication System), 1995, Vol. 09(3) pp. 5; 2002, Vol. 16(3) pp. 5; 2002, Vol. 16(4) pp. 2.
pediatric anesthetic problem register, 1999, Vol. 13(3) pp. 5
Pediatric Autism Research Act, 1998, Vol. 12(3) pp. 6
pediatric autoimmune neuropsychiatric disorders (PANDAS)
and attention, 1998, Vol. 12(2) pp. 2
intravenous gamma globulin for, 1999, Vol. 13(1) pp. 5
from monoclonal antibody D8/17, 1999, Vol. 13(1) pp. 5
plasma pheresis for, 1999, Vol. 13(1) pp. 5; 1999, Vol. 13(3) pp. 7.
from streptococcal infections, 1998, Vol. 12(2) pp. 2; 2002, Vol. 16(1) pp. 4.
pediazole, 1992, Vol. 06(4) pp. 4
peer relationships, 2002, Vol. 16(3) pp. 1
peer training, 1987, Vol. 01(2) pp. 5
peer tutors, 1988, Vol. 02(1) pp. 7; 1994, Vol. 08(4) pp. 6.
Peet, Malcolm, 1999, Vol. 13(1) pp. 7
Pekow, Charles, 1990, Vol. 04(4) pp. 6
pemoline (Cylert), 2000, Vol. 14(1) pp. 2
Pennsylvania, 2004, Vol. 18(4) pp. 3
pentoxifylline (PTX), 1997, Vol. 11(1) pp. 1; 1997, Vol. 11(2) pp. 7.
Penzel, Fred, 1997, Vol. 11(2) pp. 1–2
people-first language, 1992, Vol. 06(3) pp. 6; 1993, Vol. 07(4) pp. 3; 1994, Vol. 08(1) pp. 6.
Pepcid (famotidine)
Pepperberg, Irene M., 2001, Vol. 15(1) pp. 6
peptidase, 2000, Vol. 14(1) pp. 6
peptide analysis, 2000, Vol. 14(1) pp. 7
peptide analysis website, 2002, Vol. 16(1) pp. 7
peptides
ACTH, 1998, Vol. 12(1) pp. 6
and behavior disturbances, 1991, Vol. 05(4) pp. 2; 1997, Vol. 11(3) pp. 4.
from casein, 2002, Vol. 16(3) pp. 6
casomorphin, 1999, Vol. 13(2) pp. 1; 2003, Vol. 17(4) pp. 4.
and celiac disease, 1993, Vol. 07(1) pp. 4
cerebrolysin for cognitive functions, 2003, Vol. 17(3) pp. 5
cross-reactive peptides, 2002, Vol. 16(3) pp. 6
diets for abnormalities with, 2002, Vol. 16(3) pp. 1
DPP IV (dipeptidyl peptidase IV) protein, 2002, Vol. 16(2) pp. 4
enzymes for, 2002, Vol. 16(1) pp. 3
galanin, 2003, Vol. 17(3) pp. 4
and gastrointestinal symptoms, 1998, Vol. 12(1) pp. 1
and immune dysfunction, 1991, Vol. 05(4) pp. 2
from infectious agents, 2002, Vol. 16(3) pp. 6
intolerances to foods, 1987, Vol. 01(2) pp. 4; 1992, Vol. 06(1) pp. 7; 1993, Vol. 07(1) pp. 4; 1995, Vol. 09(4) pp. 5.
markers for autism subtypes, 1987, Vol. 01(2) pp. 4
as neurotransmitters, 2002, Vol. 16(1) pp. 7
opioids, 1989, Vol. 03(3) pp. 7; 1993, Vol. 07(1) pp. 4; 1993, Vol. 07(4) pp. 4; 1998, Vol. 12(1) pp. 1.
proteins and schizophrenia, 1999, Vol. 13(2) pp. 1
self injury and ACTH, 1998, Vol. 12(1) pp. 6
social peptides, 1993, Vol. 07(4) pp. 4
and tantrums, 1991, Vol. 05(4) pp. 2
vitamin B6 and, 1992, Vol. 06(1) pp. 7; 1993, Vol. 07(1) pp. 4.
perceptual feedback, 1988, Vol. 02(2) pp. 2
perceptual problems, 1997, Vol. 11(1) pp. 5
Perceptual Science Laboratory, 2001, Vol. 15(4) pp. 5
perchlorate
Percy, Alan, 1992, Vol. 06(1) pp. 2
perfect pitch, 2003, Vol. 17(4) pp. 4
Pericak-Vance, Margaret A., 2001, Vol. 15(2) pp. 5; 2003, Vol. 17(1) pp. 6.
peripheral neuropathy, 1996, Vol. 10(3) pp. 3; 1997, Vol. 11(4) pp. 3; 2001, Vol. 15(3) pp. 7.
Perkins, M., 1992, Vol. 06(1) pp. 4
permissiveness, 1987, Vol. 01(1) pp. 3
Peroutka, Stephen, 1989, Vol. 03(1) pp. 4
Perry, D. W., 1997, Vol. 11(2) pp. 4
Perry, Elaine K., 2001, Vol. 15(3) pp. 7
Perry, Richard, 1994, Vol. 08(3) pp. 3; 1995, Vol. 09(1) pp. 5.
perseveration
from Epstein-Barr infection, 2001, Vol. 15(1) pp. 4
gluten-free and casein-free diet for, 1997, Vol. 11(1) pp. 6
Prozac for, 1995, Vol. 09(1) pp. 2; 1999, Vol. 13(2) pp. 2.
risperidone for, 1996, Vol. 10(2) pp. 2
vitamin B6 for, 1992, Vol. 06(1) pp. 7
Persico, Antonio M., 2000, Vol. 14(1) pp. 1; 2001, Vol. 15(2) pp. 1.
perspective, 2003, Vol. 17(1) pp. 5
Perspectives on the Use of Nonaversive and Aversive Interventions for Persons with Developmental Disabilities (ed. Repp and Singh), 1991, Vol. 05(2) pp. 7
pertussis vaccine, 1996, Vol. 10(1) pp. 3
"pervasive," 1991, Vol. 05(2) pp. 2; 1991, Vol. 05(4) pp. 7.
pervasive developmental disorder (PDD)
and anxiety, 1996, Vol. 10(4) pp. 2; 1998, Vol. 12(4) pp. 4.
as diagnostic label, 1991, Vol. 05(2) pp. 2; 1991, Vol. 05(4) pp. 7; 1993, Vol. 07(2) pp. 3.
olanzapine for, 1999, Vol. 13(3) pp. 4
and related disorders, 1999, Vol. 13(1) pp. 6
and SSRIs, 1996, Vol. 10(4) pp. 2
supplements for, 2002, Vol. 16(4) pp. 4
trinucleotide sequence similarities in siblings with, 1996, Vol. 10(4) pp. 5
PET (positron emission tomography) scans, 1988, Vol. 02(1) pp. 4
pet therapy, 1989, Vol. 03(4) pp. 2
Peter, Laurence J., 1990, Vol. 04(1) pp. 6
Peter Principle (Peter), 1990, Vol. 04(1) pp. 6
Peter (savant), 1989, Vol. 03(1) pp. 3
Peters, Jimmy, 1994, Vol. 08(4) pp. 2
Peters, K. K. (Judge), 1992, Vol. 06(3) pp. 1
Peters, Sarika, 2004, Vol. 18(4) pp. 6
Petersilia, Joan, 2000, Vol. 14(2) pp. 6–7
Petit, M., 1990, Vol. 04(1) pp. 7
Petty, L., 1987, Vol. 01(3) pp. 4
Pfeiffer Treatment Center, 1997, Vol. 11(3) pp. 1; 2004, Vol. 18(4) pp. 7.
Pfizer (drug company), 2004, Vol. 18(4) pp. 3
Pharmaceutical Information Network, 1996, Vol. 10(3) pp. 4
pharmaceutical treatments. See drugs
pharmacy errors, 1996, Vol. 10(3) pp. 4
phenobarbital, 1990, Vol. 04(1) pp. 6; 1991, Vol. 05(1) pp. 3; 1993, Vol. 07(4) pp. 5; 2004, Vol. 18(3) pp. 4.
phenol-alanine, 2002, Vol. 16(1) pp. 7
phenol-sulphotransferase-P, 1994, Vol. 08(1) pp. 4
phenols
phenylalanine, 2003, Vol. 17(3) pp. 6
phenylketonuia (PKU)
phenytoin (Dilantin)
for epilepsy, 1993, Vol. 07(4) pp. 5
and ketogenic diet for seizures compared, 2002, Vol. 16(2) pp. 5
potency of generic and non-generic phenytoin compared, 2001, Vol. 15(4) pp. 4
and risperidone, 1996, Vol. 10(2) pp. 2
and vitamin D deficiency, 2004, Vol. 18(3) pp. 4
Philippart, Michel, 1987, Vol. 01(2) pp. 6; 1989, Vol. 03(1) pp. 4; 1990, Vol. 04(3) pp. 5.
Philippines, 2003, Vol. 17(1) pp. 7
Phillip Institute, 1992, Vol. 06(1) pp. 1
Phillips, Lou Diamond, 2004, Vol. 18(3) pp. 1
Phillips, Wendy, 1993, Vol. 07(2) pp. 4
phobias, 1998, Vol. 12(4) pp. 4
physical peculiarities, 2000, Vol. 14(1) pp. 4
Physicians Committee for Responsible Medicine (PCRM)
Physicians for Social Responsibility, 2000, Vol. 14(3) pp. 1
Piazza, Cathleen, 1997, Vol. 11(4) pp. 6
pica
cigarette pica, 1999, Vol. 13(4) pp. 5
and heavy-metal poisoning, 1988, Vol. 02(2) pp. 4; 2001, Vol. 15(4) pp. 7.
non-aversives for, 1988, Vol. 02(3) pp. 2
reinforcing incompatible behaviors for, 1988, Vol. 02(1) pp. 5; 1994, Vol. 08(4) pp. 5.
sensory stimulation for, 1992, Vol. 06(3) pp. 6
vitamin supplements for, 2001, Vol. 15(1) pp. 7
Piccolo, Richard, 1998, Vol. 12(1) pp. 3
Pichichero, Michael, 2002, Vol. 16(1) pp. 4
picky eating, 2003, Vol. 17(4) pp. 5
picture books, 1994, Vol. 08(3) pp. 7
Picture-Exchange Communication System (PECS), 1995, Vol. 09(3) pp. 5; 2002, Vol. 16(3) pp. 5; 2002, Vol. 16(4) pp. 2.
pictures, 1998, Vol. 12(4) pp. 6–7
Pierce, Karen L., 1994, Vol. 08(3) pp. 7; 2000, Vol. 14(3) pp. 4; 2004, Vol. 18(3) pp. 7.
Pietz, J., 1994, Vol. 08(1) pp. 1; 1995, Vol. 09(4) pp. 3; 1996, Vol. 10(3) pp. 3.
Piggott, Leonard, 1987, Vol. 01(3) pp. 2
pill taking, 2001, Vol. 15(4) pp. 7
pimozine (ORAP), 2000, Vol. 14(1) pp. 4
Pina, Jorge, 1989, Vol. 03(4) pp. 2
Pinchichero, Michael E., 2002, Vol. 16(4) pp. 1
pineal gland, 1994, Vol. 08(3) pp. 2
pink disease, 2000, Vol. 14(4) pp. 3
piracetam, 1995, Vol. 09(1) pp. 6; 1996, Vol. 10(2) pp. 7.
Pisani, David (March of Dimes), 2000, Vol. 14(2) pp. 6
pitocin, 1996, Vol. 10(3) pp. 2; 1997, Vol. 11(4) pp. 7; 2001, Vol. 15(1) pp. 4.
Pitsas, Marian, 1993, Vol. 07(4) pp. 6; 1994, Vol. 08(1) pp. 5.
Pittler, Max H., 2000, Vol. 14(2) pp. 4
pituitary, 1987, Vol. 01(4) pp. 7; 1991, Vol. 05(2) pp. 5.
Piven, Joseph, 1991, Vol. 05(2) pp. 4; 1995, Vol. 09(3) pp. 2; 1998, Vol. 12(3) pp. 2; 1999, Vol. 13(2) pp. 6.
pivotal response training, 1992, Vol. 06(2) pp. 5; 1994, Vol. 08(1) pp. 5; 1995, Vol. 09(3) pp. 4.
PKU. See phenylketonuria
plasmapheresis, 1996, Vol. 10(3) pp. 1; 1999, Vol. 13(1) pp. 5; 1999, Vol. 13(3) pp. 7.
play
ABA (Applied Behavior Analysis) for, 2002, Vol. 16(2) pp. 2
cerebrolysin for, 2003, Vol. 17(3) pp. 5
correspondence training, 1991, Vol. 05(4) pp. 5
developmentally appropriate and age appropriate compared, 1994, Vol. 08(2) pp. 5
differential reinforcement of other behaviors (DRO) for, 1989, Vol. 03(1) pp. 5
fixation channeling for, 1999, Vol. 13(2) pp. 5
PECS (Picture Exchange Communication System) for, 2002, Vol. 16(4) pp. 2
pivotal response training, 1995, Vol. 09(3) pp. 5
PLAY Project, 2003, Vol. 17(2) pp. 5
pretend play, 1996, Vol. 10(2) pp. 6
prism lenses for, 2001, Vol. 15(2) pp. 5
sensory integration therapy for, 1997, Vol. 11(4) pp. 5; 1999, Vol. 13(2) pp. 5.
special friends for, 1990, Vol. 04(1) pp. 5
spontaneous play, 1988, Vol. 02(1) pp. 7; 1988, Vol. 02(2) pp. 6.
supplements for, 1992, Vol. 06(1) pp. 7; 1993, Vol. 07(4) pp. 6; 1996, Vol. 10(3) pp. 7; 2000, Vol. 14(2) pp. 7.
training in, 1989, Vol. 03(3) pp. 5
two-trainer therapy model for teaching, 2001, Vol. 15(1) pp. 6
valproic acid for, 1994, Vol. 08(2) pp. 7
PLAY Project, 2003, Vol. 17(2) pp. 5
Please Don't Say Hello (Gold), 1989, Vol. 03(3) pp. 6
Plienis, Anthony, 1988, Vol. 02(4) pp. 2
Plioplys, Andreas, 1989, Vol. 03(2) pp. 7; 1998, Vol. 12(2) pp. 1; 2004, Vol. 18(3) pp. 6.
Plioplys, Audrius V., 1994, Vol. 08(2) pp. 4
Plochl, E., 1996, Vol. 10(3) pp. 4
PMA (Prorated Mental Age), 1987, Vol. 01(3) pp. 6
PMS. See premenstrual syndrome
pneumoccoccus, 2001, Vol. 15(2) pp. 1
pneumonia, 1988, Vol. 02(3) pp. 4
poliomyelitis, 1996, Vol. 10(1) pp. 3
"Polluting our Future" (report by National Environmental Trust, Physicians for Social Responsibility, and the Learning Disabilities Association of America), 2000, Vol. 14(3) pp. 1
pollution. See toxics
polycythemia, 2004, Vol. 18(1) pp. 6
polydipsia, 1997, Vol. 11(1) pp. 2; 1999, Vol. 13(2) pp. 4.
polymicrogyria, 1990, Vol. 04(3) pp. 4
Pomeranz, Kenneth, 1998, Vol. 12(3) pp. 7
Pondimin. See fenfluramine (Pondimin)
pons, 1988, Vol. 02(4) pp. 1
Pope, Sharon T., 1997, Vol. 11(2) pp. 5
Popper, Charles W., 2002, Vol. 16(1) pp. 2
population studies, 1989, Vol. 03(2) pp. 1
Popynick, Michele, 1994, Vol. 08(1) pp. 5
Porter, Basil, 1992, Vol. 06(3) pp. 5
Porterville Developmental Center, 1997, Vol. 11(1) pp. 3
Posey, David J., 2000, Vol. 14(1) pp. 5; 2004, Vol. 18(4) pp. 5.
positive practice overcorrection, 2001, Vol. 15(1) pp. 5
positive practice skills training, 1987, Vol. 01(1) pp. 5
positive reinforcement, 1987, Vol. 01(1) pp. 3; 1988, Vol. 02(3) pp. 1; 1990, Vol. 04(2) pp. 6.
Posner test, 1993, Vol. 07(3) pp. 4
posterior temporal fusiform gyrus, 2002, Vol. 16(4) pp. 4
posture, 2000, Vol. 14(4) pp. 4; 2001, Vol. 15(2) pp. 5; 2004, Vol. 18(4) pp. 5.
potentializer, 1987, Vol. 01(3) pp. 3
Potenza, M. N., 1999, Vol. 13(3) pp. 4
potty training. See toilet training
Povich, Maury, 1993, Vol. 07(2) pp. 6
Powell, Ellen (March of Dimes), 2000, Vol. 14(2) pp. 6
Power of Positive Thinking (Peale), 1994, Vol. 08(3) pp. 6
Powers, Michael D., 1990, Vol. 04(1) pp. 7; 1991, Vol. 05(3) pp. 5.
P5P, 2001, Vol. 15(4) pp. 3
PPI (prepulse inhibition), 2003, Vol. 17(2) pp. 2
Prader-Willi syndrome, 1990, Vol. 04(3) pp. 5; 1997, Vol. 11(4) pp. 4; 2001, Vol. 15(3) pp. 6; 2003, Vol. 17(1) pp. 6.
Pranzatelli, Michael, 1987, Vol. 01(3) pp. 2
prefrontal cortex, 2002, Vol. 16(1) pp. 1
premenstrual syndrome (PMS)
and aggression, 1998, Vol. 12(3) pp. 6; 2000, Vol. 14(3) pp. 5; 2001, Vol. 15(1) pp. 4.
contraceptives for, 1999, Vol. 13(2) pp. 7; 2000, Vol. 14(3) pp. 5.
NSAIDs (nonsteroidal anti-inflammatory drugs) for, 2000, Vol. 14(3) pp. 5; 2001, Vol. 15(1) pp. 4.
supplements for, 1998, Vol. 12(3) pp. 6; 2000, Vol. 14(3) pp. 5; 2001, Vol. 15(1) pp. 4.
premutations, 1995, Vol. 09(3) pp. 1
prenatal factors. See also birth conditions
and autistic offspring, 1988, Vol. 02(1) pp. 4
birth defects montitoring program, 2000, Vol. 14(2) pp. 1
brain abnormalities, 1990, Vol. 04(1) pp. 4; 1990, Vol. 04(3) pp. 4; 1993, Vol. 07(1) pp. 5.
fetal alcohol, 1992, Vol. 06(4) pp. 5; 1998, Vol. 12(1) pp. 5.
and fingerprints, 1990, Vol. 04(2) pp. 4
genetic damage, 1995, Vol. 09(1) pp. 2; 1997, Vol. 11(2) pp. 2; 2001, Vol. 15(2) pp. 2.
HLAs (human leukocyte antigens) as markers, 1987, Vol. 01(2) pp. 2; 1989, Vol. 03(2) pp. 2.
influenza in mother, 2003, Vol. 17(2) pp. 2
iron overload, 2001, Vol. 15(3) pp. 6
and late-onset autism, 1994, Vol. 08(4) pp. 4
and liver detoxification in autistics, 1998, Vol. 12(3) pp. 2
male offspring prevalence, 1989, Vol. 03(2) pp. 2
from mercury, 2003, Vol. 17(1) pp. 7; 2004, Vol. 18(1) pp. 4.
miscarriage threat, 2002, Vol. 16(4) pp. 2
premature births and toxics, 2000, Vol. 14(3) pp. 1
and reelin gene in autism, 2001, Vol. 15(2) pp. 1
RhoGam shots, 2003, Vol. 17(1) pp. 7
and seizure drugs in-utero, 1998, Vol. 12(1) pp. 5
seizures from iron overload, 2001, Vol. 15(3) pp. 6
and skin disorders in autistics, 1998, Vol. 12(1) pp. 4
stress during pregnancy and autistic offspring, 2001, Vol. 15(4) pp. 7
supplements, 1995, Vol. 09(1) pp. 4; 1997, Vol. 11(2) pp. 2.
supplements for, 1989, Vol. 03(2) pp. 4
terbutaline, 2004, Vol. 18(3) pp. 6; 2004, Vol. 18(4) pp. 7.
THC (tetrahydrocannabinol), 2003, Vol. 17(1) pp. 4
toxics, 1998, Vol. 12(3) pp. 2; 2000, Vol. 14(3) pp. 1.
twinning in autistics' families, 2001, Vol. 15(4) pp. 5
valproic acid in-utero, 1998, Vol. 12(1) pp. 5; 2000, Vol. 14(3) pp. 5.
vitamin A excess, 1995, Vol. 09(4) pp. 5
prepulse inhibition (PPI), 2003, Vol. 17(2) pp. 2
Prescott, James, 1987, Vol. 01(3) pp. 3
prevalence
of Asperger's, 1990, Vol. 04(3) pp. 4
of autism, 1989, Vol. 03(2) pp. 1; 2001, Vol. 15(2) pp. 2; 2002, Vol. 16(3) pp. 1; 2002, Vol. 16(4) pp. 1; 2003, Vol. 17(1) pp. 1.
of PDD, 2004, Vol. 18(3) pp. 4
of Tourette's, 2001, Vol. 15(4) pp. 5
Prevent Autism Now, 1994, Vol. 08(3) pp. 6
Prevnar, 2001, Vol. 15(2) pp. 1
priaprism, 2002, Vol. 16(4) pp. 6–7
Price, Michael Lee, 1996, Vol. 10(4) pp. 7
Princeton Child Development Institute, 1992, Vol. 06(2) pp. 5; 1994, Vol. 08(3) pp. 3.
Princeton/Eden Research Award, 1995, Vol. 09(2) pp. 3
Principles of Teaching (Peter), 1990, Vol. 04(1) pp. 6
Prior, Margot
prism lenses
for attention, 1998, Vol. 12(3) pp. 6
for behaviors, 1999, Vol. 13(3) pp. 6
for facial expression, 2001, Vol. 15(2) pp. 5
for gait problems, 1996, Vol. 10(4) pp. 4
Irlen lenses, 1995, Vol. 09(2) pp. 2; 1995, Vol. 09(4) pp. 6; 1996, Vol. 10(4) pp. 3.
for posture, 2001, Vol. 15(2) pp. 5
for strabismus, 1999, Vol. 13(3) pp. 6
"Prisoners of Silence" (PBS Frontline TV show), 1993, Vol. 07(4) pp. 7
Prizant, Barry, 1990, Vol. 04(3) pp. 6
probiotics, 1988, Vol. 02(2) pp. 3; 2000, Vol. 14(3) pp. 2; 2001, Vol. 15(3) pp. 4.
professional associations
Agency for Health Care Policy and Research, 1994, Vol. 08(4) pp. 2
Alberta Teachers' Assocation, 1995, Vol. 09(4) pp. 7
American Academy of Child and Adolescent Psychiatry, 1994, Vol. 08(2) pp. 2
American Academy of Neurology, 2000, Vol. 14(3) pp. 4
American Academy of Pediatrics, 1994, Vol. 08(2) pp. 2; 2001, Vol. 15(3) pp. 2; 2002, Vol. 16(3) pp. 3; 2004, Vol. 18(2) pp. 3.
American Association on Mental Retardation, 1994, Vol. 08(2) pp. 2
American Federation of Teachers, 1993, Vol. 07(4) pp. 2; 1995, Vol. 09(4) pp. 1.
American Medical Association, 2001, Vol. 15(3) pp. 3
American Psychiatric Association, 2001, Vol. 15(3) pp. 3
American Psychological Association, 1994, Vol. 08(2) pp. 2; 1994, Vol. 08(3) pp. 7.
American Speech-Language-Hearing Association, 1994, Vol. 08(3) pp. 7
Association for Science in Autism Treatment (ASAT), 1999, Vol. 13(3) pp. 3
Association of American Physicians and Surgeons, 1999, Vol. 13(3) pp. 1
Child Neurology Society, 2000, Vol. 14(3) pp. 4
Council for Exceptional Children, 1993, Vol. 07(4) pp. 2
Council for Learning Disabilities, 1993, Vol. 07(4) pp. 2
Environmental Health Sciences, National Institute of
"Role of the Environment in Autism" (conference), 2000, Vol. 14(4) pp. 3
Learning Disabilities Association of America, 1993, Vol. 07(4) pp. 2
National Alliance for Autism Research, 2000, Vol. 14(4) pp. 3
National Center for Complementary and Alternative Medicine, 2001, Vol. 15(1) pp. 7
National Education Association, 1995, Vol. 09(4) pp. 1
National Institute of Environmental Health Sciences (NIEHS), 2000, Vol. 14(4) pp. 3
National School Boards Association, 1995, Vol. 09(4) pp. 1
Vaccine Safety Committee of the Institute of Medicine, 2002, Vol. 16(2) pp. 1
prognosis
program referral list, 1997, Vol. 11(2) pp. 4
Project Peer, 1988, Vol. 02(1) pp. 6
prolactin, 1987, Vol. 01(4) pp. 7; 1999, Vol. 13(4) pp. 4; 2001, Vol. 15(2) pp. 4.
prompts, 1988, Vol. 02(1) pp. 7
Proos, Ylle, 1991, Vol. 05(3) pp. 2
property damage, 1997, Vol. 11(2) pp. 6; 2002, Vol. 16(2) pp. 7; 2003, Vol. 17(1) pp. 3.
propofol, 1999, Vol. 13(3) pp. 5
propranolol, 1990, Vol. 04(3) pp. 7
proprioception, 1987, Vol. 01(3) pp. 3; 1988, Vol. 02(4) pp. 3; 1998, Vol. 12(3) pp. 3. See also balance
Prorated Mental Age, 1987, Vol. 01(3) pp. 6
prosopagnosia, 2004, Vol. 18(3) pp. 7. See also face blindness
proteins
adenosine deaminase binding, 2003, Vol. 17(4) pp. 4
c-Fos, 2001, Vol. 15(4) pp. 2
calprotectin, 2001, Vol. 15(2) pp. 1
CD26, 2003, Vol. 17(4) pp. 4
chemokines, 2004, Vol. 18(4) pp. 1–2
cytokines, 2004, Vol. 18(4) pp. 1–2
dipeptidylpeptidase IV (DPPIV), 2002, Vol. 16(2) pp. 4; 2003, Vol. 17(4) pp. 4.
enzymes for breakdown of, 2002, Vol. 16(2) pp. 4
FMRP in Fragile X, 2001, Vol. 15(2) pp. 4
metallothionein, 2001, Vol. 15(2) pp. 4
myelin basic protein (MBP), 1993, Vol. 07(1) pp. 5; 2000, Vol. 14(4) pp. 1; 2004, Vol. 18(2) pp. 1; 2004, Vol. 18(4) pp. 4.
neuron-axal filament 200-Kd, 2004, Vol. 18(4) pp. 4
reelin, 2001, Vol. 15(2) pp. 1; 2003, Vol. 17(2) pp. 2.
zonulin, 2000, Vol. 14(2) pp. 2
zot, 2000, Vol. 14(2) pp. 2
protodeclarative pointing, 1996, Vol. 10(2) pp. 6
Prozac. See fluoxetine (Prozac)
pseudo-language, 1989, Vol. 03(1) pp. 2
Psillas, George, 2003, Vol. 17(3) pp. 4
psychogenic model, 1989, Vol. 03(3) pp. 3; 2001, Vol. 15(3) pp. 3.
Psychological Medicine, 1988, Vol. 02(4) pp. 1
psychomotor seizures, 1990, Vol. 04(1) pp. 4
psychosis, 1988, Vol. 02(4) pp. 7; 2003, Vol. 17(1) pp. 5.
Public Health Service, U.S., 1992, Vol. 06(3) pp. 5; 2004, Vol. 18(2) pp. 3; 2004, Vol. 18(4) pp. 2.
PubMed, 2001, Vol. 15(1) pp. 7
PUFAs (omega-3 polyunsaturated fatty acids)
pulmonary hypertension, 1996, Vol. 10(3) pp. 4; 1997, Vol. 11(1) pp. 5.
Pumpian, Ian, 1990, Vol. 04(3) pp. 2
punishment. See aversives
Purdon, Scot E., 1994, Vol. 08(4) pp. 1; 1996, Vol. 10(2) pp. 2.
purines
and ADA (adenosine deaminase) variants, 2001, Vol. 15(1) pp. 2; 2001, Vol. 15(2) pp. 2; 2003, Vol. 17(4) pp. 4.
in autism subgroup, 1990, Vol. 04(1) pp. 2; 1990, Vol. 04(2) pp. 7.
diagnostic test, 1987, Vol. 01(2) pp. 1
in Lesch-Nyhan disorder, 1988, Vol. 02(3) pp. 3
Purkinje cells. See also amygdala deficiencies, See also cerebellum deficiencies
in amydala, 1989, Vol. 03(1) pp. 1
in cerebellum, 1989, Vol. 03(1) pp. 4; 1998, Vol. 12(4) pp. 6; 2000, Vol. 14(3) pp. 5; 2001, Vol. 15(4) pp. 1; 2002, Vol. 16(3) pp. 4; 2003, Vol. 17(1) pp. 6; 2004, Vol. 18(3) pp. 6; 2004, Vol. 18(4) pp. 1.
putamen, 1997, Vol. 11(4) pp. 4
pyridoxal phosphate (PLP), 2004, Vol. 18(4) pp. 4
pyridoxine, 2002, Vol. 16(2) pp. 2. See also vitamin B6
pyridoxine-dependent epilepsy, 2002, Vol. 16(2) pp. 2
pyroluria, 1997, Vol. 11(3) pp. 1
© copyright 2005, 2006 Autism Research Institute
|
|
